Invention Grant
- Patent Title: SOS1 inhibitors
-
Application No.: US17127582Application Date: 2020-12-18
-
Publication No.: US11702418B2Publication Date: 2023-07-18
- Inventor: Matthew Arnold Marx , John Michael Ketcham , Christopher Ronald Smith , John David Lawson , Aaron Craig Burns , Xiaolun Wang , Svitlana Kulyk , Anthony Ivetac
- Applicant: Mirati Therapeutics, Inc.
- Applicant Address: US CA San Diego
- Assignee: MIRATI THERAPEUTICS, INC.
- Current Assignee: MIRATI THERAPEUTICS, INC.
- Current Assignee Address: US CA San Diego
- Agency: Wood, Phillips, Katz, Clark & Mortimer
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D237/34 ; C07D403/04 ; C07D409/12 ; C07D409/14 ; C07D413/04 ; C07D471/04 ; C07D471/08 ; C07D487/08 ; C07D487/10 ; C07D498/10 ; C07D471/10
Abstract:
The present invention relates to compounds that inhibit Son of sevenless homolog 1 (SOS1) activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention.
Public/Granted literature
- US20210188857A1 SOS1 INHIBITORS Public/Granted day:2021-06-24
Information query
